The previous page is sending you to https://www.adcreview.com/news/pyxis-oncology-to-evaluate-the-safety-tolerability-pharmacokinetics-pharmacodynamics-and-preliminary-efficacy-of-pyx-201-in-phase-1-study/.

 If you do not want to visit that page, you can return to the previous page.